Joon Lee
Stock Analyst at Truist Securities
(2.73)
# 496
Out of 5,297 analysts
133
Total ratings
52.63%
Success rate
33.72%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics | Maintains: Strong Buy | 76 150 | 83.97 | 78.64% | 8 | Mar 31, 2025 | |
NTLA Intellia Therapeutic... | Maintains: Buy | 90 50 | 7.32 | 583.06% | 4 | Mar 4, 2025 | |
PRAX Praxis Precision Med... | Maintains: Buy | 175 85 | 37.12 | 128.99% | 5 | Mar 3, 2025 | |
AXSM Axsome Therapeutics | Maintains: Strong Buy | 190 200 | 109.9 | 81.98% | 5 | Feb 19, 2025 | |
CRSP CRISPR Therapeutics | Maintains: Strong Buy | 100 120 | 34.2 | 250.88% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 460 520 | 483.76 | 7.49% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 2.19 | 721.92% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 660 700 | 582.28 | 20.22% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | 3.7 | 332.43% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 44 57 | 60.44 | -5.69% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 36 | 7.54 | 377.45% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 36 | 24.5 | 46.94% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 1.19 | 572.27% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 13 8 | 7.78 | 2.83% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 17 | 6.33 | 168.56% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 60 | n/a | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 90 | 68.35 | 31.68% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 40 | 4.29 | 832.4% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | n/a | n/a | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 120 | 25.68 | 367.29% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 65 | 7.15 | 809.09% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 | 126.39 | 58.24% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | 1.32 | 278.79% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.42 | 426.32% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 25 | n/a | n/a | 2 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 280 | 2.71 | 10232.1% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 45 50 | n/a | n/a | 1 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 | 0.28 | 128471.43% | 2 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 27 34 | 18.97 | 79.23% | 1 | Mar 16, 2021 |